NEXTBIOMEDICAL is a company specializing in innovative therapeutic materials based on the drug delivery system. NEXTBIOMEDICAL has been mainly conducting R&D, and manufacturing the drug-device combination products which reflect the clinical unmet needs.
The company is recognized for its technology and quality management system through European CE certification, including GMP certification for manufacturing facilities and approval for New Health Technology.
NEXTBIOMEDICAL has developed the 1st ever resorbable microspheres (Nexsphere & Nexsphere-F) for tailored endovascular embolization. Nexsphere is indicated for use in embolization of liver cancer, uterine fibroids, prostatic hyperplasia & arterial bleeding and Nexsphere-F is indicated for Musculoskeletal (MSK) embolization.